Media stories about Davita (NYSE:DVA) have been trending somewhat positive on Thursday, AlphaOne Sentiment Analysis reports. The research group, a service of Accern, identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Davita earned a news impact score of 0.04 on AlphaOne’s scale. AlphaOne also assigned headlines about the company an impact score of 87 out of 100, indicating that recent press coverage is very likely to have an effect on the company’s share price in the immediate future.
Here are some of the headlines that may have impacted AlphaOne Sentiment Analysis’s rankings:
- $3.69 Billion in Sales Expected for Davita Inc (DVA) This Quarter (americanbankingnews.com)
- Analysts Opinion Summary on: DaVita Inc. (DVA) – StandardOracle (standardoracle.com)
- DaVita, Inc. – Value Analysis (NYSE:DVA) : April 12, 2017 (finance.yahoo.com)
- $0.82 EPS Expected for Davita Inc (DVA) This Quarter (americanbankingnews.com)
- DaVita Inc. — Moody’s upgrades DaVita’s CFR to Ba2; outlook is stable (finance.yahoo.com)
Several equities research analysts have issued reports on the company. TheStreet raised Davita from a “c+” rating to a “b-” rating in a research note on Monday, April 3rd. Royal Bank of Canada reaffirmed a “hold” rating and set a $62.00 price target on shares of Davita in a research note on Friday, February 17th. Finally, Zacks Investment Research lowered Davita from a “hold” rating to a “sell” rating in a research note on Tuesday, January 31st. One analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $71.44.
Davita (NYSE:DVA) traded down 0.46% on Thursday, hitting $67.79. The stock had a trading volume of 387,470 shares. The company’s 50 day moving average price is $68.12 and its 200 day moving average price is $64.50. Davita has a 52-week low of $54.50 and a 52-week high of $78.77. The firm has a market cap of $13.19 billion, a price-to-earnings ratio of 15.80 and a beta of 1.02.
Davita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 16th. The company reported $0.98 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.07. Davita had a return on equity of 16.16% and a net margin of 4.92%. The business earned $3.72 billion during the quarter, compared to analyst estimates of $3.74 billion. During the same quarter in the prior year, the business posted $1.12 EPS. Davita’s revenue for the quarter was up 5.2% compared to the same quarter last year. Analysts expect that Davita will post $3.57 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “Davita (DVA) Receives Daily Media Sentiment Rating of 0.04” was reported by sleekmoney and is owned by of sleekmoney. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at http://sleekmoney.com/davita-dva-receives-daily-media-sentiment-rating-of-0-04/1739385.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/davita-dva-receives-daily-media-sentiment-rating-of-0-04/1739385.html
Receive News & Ratings for Davita Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita Inc and related companies with MarketBeat.com's FREE daily email newsletter.